相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Database resources of the national center for biotechnology information
Eric W. Sayers et al.
NUCLEIC ACIDS RESEARCH (2022)
Anticancer Activities of Mushrooms: A Neglected Source for Drug Discovery
Sujogya Kumar Panda et al.
PHARMACEUTICALS (2022)
Overview of Research into mTOR Inhibitors
Beibei Mao et al.
MOLECULES (2022)
In Silico Strategy for Targeting the mTOR Kinase at Rapamycin Binding Site by Small Molecules
Serena Vittorio et al.
MOLECULES (2021)
Exploring Molecular Descriptors and Fingerprints to Predict mTOR Kinase Inhibitors using Machine Learning Techniques
Chetna Kumari et al.
IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS (2021)
Synergistic drug combinations and machine learning for drug repurposing in chordoma
Edward Anderson et al.
SCIENTIFIC REPORTS (2020)
Synthesis and biological evaluation of rapamycin-derived, next generation small molecules
Shiva Krishna Reddy Guduru et al.
MEDCHEMCOMM (2018)
Influence of the Novel ATP-Competitive Dual mTORC1/2 Inhibitor AZD2014 on Immune Cell Populations and Heart Allograft Rejection
Daniel Fantus et al.
TRANSPLANTATION (2017)
Discovery and Development of ATP-Competitive mTOR Inhibitors Using Computational Approaches
Yao Luo et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
mTOR Signaling in Growth, Metabolism, and Disease
Robert A. Saxton et al.
CELL (2017)
PubChem Substance and Compound databases
Sunghwan Kim et al.
NUCLEIC ACIDS RESEARCH (2016)
Resveratrol induces autophagy by directly inhibiting mTOR through ATP competition
Dohyun Park et al.
SCIENTIFIC REPORTS (2016)
Optimization of a Series of Triazole Containing Mammalian Target of Rapamycin (mTOR) Kinase Inhibitors and the Discovery of CC-115
Deborah S. Mortensen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Discovery of Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor CC-223
Deborah S. Mortensen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
g_mmpbsa-A GROMACS Tool for High-Throughput MM-PBSA Calculations
Rashmi Kumari et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Characterization of the Activity of the PI3K/mTOR Inhibitor XL765 (SAR245409) in Tumor Models with Diverse Genetic Alterations Affecting the PI3K Pathway
Peiwen Yu et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Tocotrienols Target PI3K/Akt Signaling in Anti-Breast Cancer Therapy
Paul W. Sylvester et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2013)
Inhibition of mTOR Signaling by Quercetin in Cancer Treatment and Prevention
Ansgar Bruening
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2013)
Inhibition of Akt/mTOR Signaling by the Dietary Flavonoid Fisetin
Deeba N. Syed et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2013)
Targeted Regulation of PI3K/Akt/mTOR/NF-κB Signaling by Indole Compounds and their Derivatives: Mechanistic Details and Biological Implications for Cancer Therapy
Aamir Ahmad et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2013)
Targeting the PI3K/Akt/mTOR Axis by Apigenin for Cancer Prevention
Xin Tong et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2013)
Use of core modification in the discovery of CC214-2, an orally available, selective inhibitor of mTOR kinase
Deborah S. Mortensen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: The discovery of AZD8055 and AZD2014
Kurt G. Pike et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
mTOR kinase inhibitors as potential cancer therapeutic drugs
Shi-Yong Sun
CANCER LETTERS (2013)
Bioactive ergostanoids and a new polyhydroxyoctane from Lentinus polychrous mycelia and their inhibitory effects on E2-enhanced cell proliferation of T47D cells
Niramai Fangkrathok et al.
NATURAL PRODUCT RESEARCH (2013)
Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment
Zhihong Zeng et al.
BLOOD (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor
Glenn S. Van Aller et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Definition and testing of the GROMOS force-field versions 54A7 and 54B7
Nathan Schmid et al.
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2011)
Recent advances in the discovery of small-molecule ATP competitive mTOR inhibitors: a patent review
Arie Zask et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2011)
LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery
Roman A. Laskowski et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
An Automated Force Field Topology Builder (ATB) and Repository: Version 1.0
Alpeshkumar K. Malde et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2011)
Discovery of 9-(6-Aminopyridin-3-yl)-1-(3-(trifluoromethyl)-phenyl)benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a Potent, Selective, and Orally Available Mammalian Target of Raparnycin (mTOR) Inhibitor for Treatment of Cancer
Qingsong Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Discovery of a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor (GDC-0980) for the Treatment of Cancer
Daniel P. Sutherlin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Rapamycin passes the torch: a new generation of mTOR inhibitors
Don Benjamin et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Updates of mTOR Inhibitors
Hongyu Zhou et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2010)
Allosteric and ATP-competitive kinase inhibitors of mTOR for cancer treatment
Carlos Garcia-Echeverria
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Beyond Rapalog Therapy: Preclinical Pharmacology and Antitumor Activity of WYE-125132, an ATP-Competitive and Specific Inhibitor of mTORC1 and mTORC2
Ker Yu et al.
CANCER RESEARCH (2010)
NVP-BEZ235 as a New Therapeutic Option for Sarcomas
Maria C. Manara et al.
CLINICAL CANCER RESEARCH (2010)
Medicinal Mushroom Science: History, Current Status, Future Trends, and Unsolved Problems
Solomon P. Wasser
INTERNATIONAL JOURNAL OF MEDICINAL MUSHROOMS (2010)
First-in-human phase I study exploring three schedules of OSI-027, a novel small molecule TORC1/TORC2 inhibitor, in patients with advanced solid tumors and lymphoma
D. S. Tan et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Antitumor Efficacy Profile of PKI-402, a Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor
Robert Mallon et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Biochemical, Cellular, and In vivo Activity of Novel ATP-Competitive and Selective Inhibitors of the Mammalian Target of Rapamycin
Ker Yu et al.
CANCER RESEARCH (2009)
An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1
Carson C. Thoreen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Targeting Melanoma with Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitors
Romina Marone et al.
MOLECULAR CANCER RESEARCH (2009)
Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-κB pathway
Yvonne G. Lin et al.
CLINICAL CANCER RESEARCH (2007)
Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells
Christopher S. Beevers et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Flexible simple point-charge water model with improved liquid-state properties
YJ Wu et al.
JOURNAL OF CHEMICAL PHYSICS (2006)
Medicinal mushroom modulators of molecular targets as cancer therapeutics
BZ Zaidman et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2005)
Characterization of the FKBP•Rapamycin•FRB ternary complex
LA Banaszynski et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Anticancer effects of Ganoderma lucidum: A review of scientific evidence
JWM Yuen et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2005)
Integration of growth factor and nutrient signaling: Implications for cancer biology
AF Shamji et al.
MOLECULAR CELL (2003)
分享论文
